Evidence map›Paper›PMID 38213296›Full record

ArticleCancer discovery2024

UNCAN.eu: Toward a European Federated Cancer Research Data Hub.

Michael Boutros, Michael Baumann, Anna Bigas, Linda Chaabane, Julien Guérin, Jens K Habermann, Aurélien Jobard, Pier Giuseppe Pelicci, Oliver Stegle, Giovanni Tonon and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Michael BoutrosGerman Cancer Research Center (DKFZ), Division of Signaling and Functional Genomics and Heidelberg University, Medical Faculty Heidelberg, Institute for Human Genetics, Heidelberg, Germany.ORCID 0000-0002-9458-817X
Michael BaumannDKFZ, Heidelberg, Germany.ORCID 0000-0002-9340-974X
Anna BigasCentro de Investigación Biomedica en Red-Oncología (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.ORCID 0000-0003-4801-6899
Linda ChaabaneEuro-BioImaging ERIC, Med-Hub, National Research Council of Italy (CNR), Turin, Italy.ORCID 0000-0003-2782-9938
Julien GuérinIT Department, Curie Hospital, Paris, France.ORCID 0000-0002-3024-8483
Jens K HabermannInterdisciplinary Center for Biobanking-Lübeck (ICB-L), University of Lübeck, Lübeck, Germany.ORCID 0000-0002-3127-4755
Aurélien JobardInstitut National du Cancer (INCa), Boulogne Billancourt, France.ORCID 0009-0000-1443-3358
Pier Giuseppe PelicciDepartment of Experimental Oncology, IEO European Institute of Oncology IRCCS, Milano, Italy.ORCID 0000-0002-5076-2316
Oliver StegleDKFZ, Division of Computational Genomics and Systems Genetics, Heidelberg, Germany.ORCID 0000-0002-8818-7193
Giovanni TononCenter for Omics Sciences, IRCCS San Raffaele Scientific Institute, Milan, Italy.ORCID 0000-0003-2973-5038
Alfonso ValenciaBarcelona Supercomputing Center, Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.ORCID 0000-0002-8937-6789
Eva C WinklerNational Center for Tumor Diseases (NCT), Heidelberg University, Section Translational Medical Ethics, Heidelberg, Germany.ORCID 0000-0001-7460-0154
Patricia BlancImagine for Margo, Paris, France.ORCID 0000-0002-7318-8986
Ruggero De MariaFondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.ORCID 0000-0003-2255-0583
Rene H MedemaOncode Institute and The Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID 0000-0002-6754-0381
Peter NagyNational Institute of Oncology and the National Tumor Biology Laboratory, Budapest, Department of Anatomy and Histology, HUN-REN-UVMB Laboratory of Redox Biology Research Group, University of Veterinary Medicine, and Chemistry Institute, University of Debrecen, Debrecen, Hungary.ORCID 0000-0003-3393-235X
Josep TaberneroDKFZ, Division of Computational Genomics and Systems Genetics, Heidelberg, Germany.ORCID 0000-0002-2495-8139
Eric SolaryUniversité Paris-Saclay and INSERM, Gustave Roussy Cancer Center, Villejuif, France.ORCID 0000-0002-8629-1341

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To enable a collective effort that generates a new level of UNderstanding CANcer (UNCAN.eu) [Cancer Discov (2022) 12 (11): OF1], the European Union supports the creation of a sustainable platform that connects cancer research across Member States. A workshop hosted in Heidelberg gathered European cancer experts to identify ongoing initiatives that may contribute to building this platform and discuss the governance and long-term evolution of a European Federated Cancer Data Hub.

Indexed as

NeoplasmsEuropean UnionHumansResearch

Identifiers

PMID38213296
PMCPMC10784740

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.